Biotechnology

Biotechnology Industry Market Research Reports

Biotechnology Industry Market Research Reports, Analysis and Trends

 

Publication Single User License (PDF) Price
Global Proteomics Market 2015-2019

Global Proteomics Market 2015-2019

Date Published: Apr 22 2015
Report forecast the Global Proteomics market to grow at a CAGR of 8.39 percent over the period 2014-2019.
 
$2,500.00
Noscapine Hydrochloride World Report

Noscapine Hydrochloride World Report

Date Published: Apr 9 2015

NOSCAPINE HYDROCHLORIDE WORLD REPORT

The Noscapine Hydrochloride World Report gives Market Consumption / Products / Services for over 200 countries by 6 to 10-Digit NAICS Product Codes by 3 Time series: From 1997- 2015 and Forecasts 2016- 2023 & 2023-2028.

$4,250.00
Cell Analysis Global Market - Forecast To 2020

Cell Analysis Global Market - Forecast To 2020

Date Published: Apr 2 2015
Cell analysis plays a major role in gene identification, protein identification, transcription analysis and epigenomics at cellular level. It proves to be an ultra-sensitive device to elucidate specific molecular processes and pathways and reveal the nature of cell heterogenecity. Hospitals, academic institutions, government bodies, as well as pharmaceutical and biotechnology firms are increasing their focus on application of cell analysis as a modern emerging tool in research, drug discovery and diagnosis.
$4,500.00
Top 50 Big Biotech Partnering and M&A Deal Trends

Top 50 Big Biotech Partnering and M&A Deal Trends

Date Published: Apr 1 2015
The Top 50 Big Biotech Partnering and M&A Deal Trends report provides comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty big biotech companies.
 

Description

The Top 50 Big Biotech Partnering and M&A Deal Trends report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty big biotech companies.
$2,495.00
Competitor Analysis: Therapeutic Antibodies 2015 - Biosimilars & Biosuperiors

Competitor Analysis: Therapeutic Antibodies 2015 - Biosimilars & Biosuperiors

Date Published: Apr 1 2015
This Competitive Intelligence Report about Therapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products and as biosimilar versions as of April 2015.
 
$1,500.00
Finding Biopharma Licensing and Collaboration Partners

Finding Biopharma Licensing and Collaboration Partners

Date Published: Apr 1 2015
Practical steps required to prepare for partnering, prepare supporting materials, identify and shortlist potential partners and opportunities, identifying and contacting the right person in the partner company, and managing of discussions through to deal negotiation
 

Description

$1,495.00
Global Regenerative Medicine Partnering 2010-2015: Deal trends, players, financials and forecasts

Global Regenerative Medicine Partnering 2010-2015: Deal trends, players, financials and forecasts

Date Published: Apr 1 2015
The Global Regenerative Medicine Partnering 2010-2015: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

$2,995.00
GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020

GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells

Date Published: Apr 1 2015
This report provides a comprehensive overview of the size of cancer immunotherapy market, the segmentation of the market, key players and the vast potential of therapies that are in clinical trials. Oncologic therapeutics cannot cure cancer and yet in 2014, the overall market for cancer therapeutics stood at about $84.3 billion. Any drug that can provide a reasonable survival of more than five years for the cancer patients can achieve a blockbuster status.
$3,400.00
Global Co-development Deals in Pharma, Biotech & Diagnostics 2010-2015

Global Co-development Deals in Pharma, Biotech & Diagnostics 2010-2015

Date Published: Apr 1 2015
The Global Co-development Deals in Pharma, Biotech & Diagnostics 2010-2015 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading healthcare companies
 

Description

$2,995.00
Top 50 Big Pharma Partnering and M&A Deal Trends

Top 50 Big Pharma Partnering and M&A Deal Trends

Date Published: Apr 1 2015
The Top 50 Big Pharma Partnering and M&A Deal Trends report provides comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty big pharma companies.
 

Description

The Top 50 Big Pharma Partnering and M&A Deal Trends report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty big pharma companies.
 
$3,495.00
Competitor Analysis: EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux

Competitor Analysis: EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux

Date Published: Mar 28 2015
This Competitive Intelligence Report about EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux provides a competitor evaluation in the field of recombinant antibodies targeting epithelial growth factor receptor (EGF-R) to treat solid tumors as of March 2015. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date.
$288.00
Competitor Analysis: CD20 Antibodies 2015 - Biosimilars and Biosuperiors of Rituximab

Competitor Analysis: CD20 Antibodies 2015 - Biosimilars and Biosuperiors of Rituximab

Date Published: Mar 25 2015
This Competitive Intelligence Report about CD20 Antibodies 2015- Biosimilars and Biosuperiors of Rituximab provides a competitor evaluation in the field of recombinant antibodies targeting CD20 for treatment of B-cell mediated malignancies and rheumatoid arthritis as of March 2015. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date.
$346.00
Competitor Analysis: TNF Antibodies 2015– Biosimilars and Biosuperiors of Humira, Remicade and Enbrel

Competitor Analysis: TNF Antibodies 2015– Biosimilars and Biosuperiors of Humira, Remicade and Enbrel

Date Published: Mar 22 2015
The present Competitive Intelligence report about TNF Antibodies 2015– Biosimilars and Biosuperiors of Humira, Remicade and Enbrel provides a competitor evaluation in the field of recombinant antibodies targeting tumor necrosis factor (TNF) alpha or its receptor used to treat various inflammatory and autoimmune diseases as of March 2015. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date.
$577.00
Competitor Analysis: IDO & TDO Inhibitors - Novel Immune Response Checkpoint Modulators

Competitor Analysis: IDO & TDO Inhibitors - Novel Immune Response Checkpoint Modulators

Date Published: Mar 16 2015
The Competitive Intelligence report aboutIDO & TDO Inhibitors - Novel Immune Response Checkpoint Modulators provides a competitor analysis as of March 2015 in the development pipeline of novel inhibitors of indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3- dioxygenase (TDO) for treatment of cancer as monotherapy and in combination with other immune checkpoint inhibitors. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date.
$185.00
Engineered TCR and CAR Immunotherapeutics 2015

Engineered TCR and CAR Immunotherapeutics 2015

Date Published: Mar 16 2015

A comparative analysis of the landscape of and business opportunities with TCR and CAR antibodies, T cells, NK cells, TILs, DLIs & CTLs

$2,630.00
PharmaLeaders: Mid-Cap Biotechnology Benchmark Report - Sales Forecasts and Product Valuations of Innovative Biotechs

PharmaLeaders: Mid-Cap Biotechnology Benchmark Report - Sales Forecasts and Product Valuations of Innovative Biotechs

Date Published: Mar 6 2015

PharmaLeaders: Mid-Cap Biotechnology Benchmark Report - Sales Forecasts and Product Valuations of Innovative Biotechs

Summary

$3,995.00
Opportunity in the Indian Biopharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Biopharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Date Published: Mar 6 2015

Opportunity in the Indian Biopharmaceuticals Market - 2015 report provides an insight into the Opportunity in the Indian Biopharmaceuticals current market scenario, structure and practices.

In depth market scenario includes;
- Indian Biopharmaceuticals Market Size
- Market share of key players – Top companies
- Market size for Vaccines
- Market size for Diagnostics
- Market size for Therapeutics
- Market size for Other Products

$6,000.00
2015 Deep Research Report on Global Biologics and Biosimilars Industry

2015 Deep Research Report on Global Biologics and Biosimilars Industry

Date Published: Mar 3 2015
<2015 Deep Research Report on Global Biologics and Biosimilars Industry> is a professional and depth research report on Global Biologics and Biosimilars industry.
 
For overview analysis, the report introduces Biologics and Biosimilars basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc.
 
$2,600.00
Liver Cancer Partnering 2010-2015

Liver Cancer Partnering 2010-2015

Date Published: Mar 1 2015

Provides understanding and access to the liver cancer partnering deals and agreements entered into by the worlds leading healthcare companies .

Description
The Liver Cancer Partnering 2010-2015 report provides understanding and access to the liver cancer partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in liver cancer partnering deals
Top Liver cancer deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

$795.00
Acne Partnering 2010-2015

Acne Partnering 2010-2015

Date Published: Mar 1 2015

Provides understanding and access to the acne partnering deals and agreements entered into by the worlds leading healthcare companies .

Description
The Acne Partnering 2010-2015 report provides understanding and access to the acne partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in acne partnering deals
Top acne deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

$795.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&amp;G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data